In our study, the binding affinities of selected natural products towards PfTrxR, PfGR, human TrxR and human GR were determined using a mass spectrometry based ligand binding assay. The in vitro antimalarial activity and cytotoxicity of these ligands were also determined. Catharanthine, 11-(OH)-coronaridine, hernagine, vobasine and hispolone displayed antiplasmodial activity against PfK1 (IC 50 = 0.996-3.63 μg/mL).
Malaria kills more people than any other communicable disease, except tuberculosis. Mostly children are affected in Africa resulting in death or life-long health problems from delayed treatment. Quinine, a quinolone alkaloid and the first drug used to treat malaria, was isolated from the bark of Cinchona tree [1] . A number of natural products comprised of terpenes, lanostanes, flavonoids, alkaloids, peptides, phenylalkanoids, xanthones, naphthopyrones, polyketides including halenaquinones, peroxides which possess antimalarial activity have been reviewed [2] . It has been understood that the chemical diversity of natural products is a better source for successful drugs than synthetic compounds, thus shifting the emphasis to natural product drug discovery [3] . Unfortunately natural products other than quinine and artemisinin have not been in preclinical development [4] . Since quinine and artemisinin are outstanding examples of therapeutic natural products, there is a need to explore nature which is a rich source of new pharmacophores/templates that can guide the design of potentially superior analogs [4] . In our study, we have tested natural products and a curcumin analogue hispolone for their binding affinity and inhibitory activity towards Plasmodium falciparum thioredoxin reductase (PfTrxR) and Plasmodium falciparum glutathione reductase (PfGR) and their human isoforms using mass spectrometry, antiplasmodial and cytotoxicity assays.
As a result of screening of 133 natural products to identify ligands to PfTrxR, nine compounds displayed binding affinity to PfTrxR enzyme. The selectivity of these ligands was also evaluated against PfGR, and human isoforms of these enzymes. Subsequently, we tested selected compounds for inhibitory activity on PfTrxR and PfGR, and antiplasmodial activity in vitro. The lack of PfTrxR inhibitory activity of yohimbine, catharanthine, 11-(OH)coronaridine, quinidine N-oxide, hernagine, vobasine, hispolone and gnetifolin E was reported by Munigunti and Calderón [5] ( Table 1 ) and six of these compounds showed binding to PfTrxR of >2-fold and no binding to the human isoform of the enzyme ( Table  2 ). Here the lack of PfGR inhibitory activity of these compounds is reported with binding of 2-fold to PfGR and no binding to human isoform. These data suggested that the tested natural products bind non-specifically to the two targets available in our laboratory. Catharanthine, 11-(OH)-coronaridine, hernagine, vobasine and Munigunti et al.
targets.
11-(OH)-coronaridine was isolated from leaves of Catharanthus roseus (L.) G. Don. The leaf extracts of C. roseus displayed good antiplasmodial activity (IC 50 49.63 µg/mL) against P. falciparumin vitro [6] . These reports suggest that 11-(OH)coronaridine may be responsible for the antiplasmodial activity in C. roseus leaves. This is the first report on the antiplasmodial activity of these natural products.
Experimental
Chemicals and enzymes: Solvents for LC-MS analysis were purchased from Fischer Scientific International (Atlanta, GA). Eight compounds from AnalytiCon Discovery GmbH (Germany) natural products library (MEGx) were purchased based on compound classes that have reported either antimalarial activity or inhibition of TrxR [5, 7] . Hispolone was kindly provided by Dr. G. V. Subbaraju, AptuitLauras, Hyderabad, India. PfTrxR (Mr 59 kDa) and PfGR (Mr 56 kDa) enzymes were provided as a gift by Prof. Katja Becker, Justus-Liebig University, Giessen, Germany. The recombinant PfTrxR and PfGR enzymes were prepared and purified using silver-stained SDS page according to the procedure published by Kanzok et al. [8] and Farber et al. [9] , respectively. The specific activities of PfTrxR (1.9 U/mg) and PfGR enzyme (55 U/mg) were determined by DTNB [5,5-dithiobis(2-nitrobenzoic acid)] and GR assays developed by Kanzok et al. [8] . Protein concentration of enzymes was determined by Bradford method [10] .
PfTrxR and PfGR enzyme binding assay using ultrafiltration and liquid chromatography-mass spectrometry: The binding assays for PfTrxR and PfGR to identify ligands to the two enzymes were carried out as per Mulabagal et. al. [7] .
LC-MS based PfTrxR functional assay:
The functional assay, to identify inhibitors of PfTrxR was carried out as per the method developed by Mugunti et. al. [5] .
Antiplasmodial activity and IC 50 values of PfTrxR ligands:
Antiplasmodial activity was determined using the K1 strain of P. falciparum (resistant to chloroquine and pyrimethamine). A modification of the [ 3 H]-hypoxanthine incorporation assay was used. Briefly, infected human red blood cells in RPMI 1640 medium with 5% Albumax were exposed to serial drug dilutions in micro titer plates. After 48 h at 37°C in a reduced oxygen atmosphere, 0.5 μCi [ 3 H]-hypoxanthine was added to each well. Cultures were incubated for a further 24 h before they were harvested onto glass-fiber filters and washed with distilled water. The radioactivity was counted using a BetaplateTM liquid scintillation counter (Wallac, Zurich, Switzerland). The results were recorded as counts per minute (CPM) per well at each drug concentration and expressed as percentage of the untreated controls. Chloroquine was used as a reference antimalarial drug and showed an IC 50 value of 0.069 µg/mL [12] .
Cytotoxicity against L6 cells: Assays were performed in 96-well microtiter plates, each well containing 100 μL of RPMI 1640 medium supplemented with 1% L-glutamine (200 mM) and 10% fetal bovine serum, and 4 × 10 4 L6 cells (a cell line derived from rat skeletal myoblasts). Serial drug dilutions of seven 3-fold dilution steps covering a range from 90 to 0.123 μg/mL were prepared. After 72 h of incubation, the plates were inspected under an inverted microscope to assure growth of the controls and sterile conditions. 10 μL of Alamar Blue solution was then added to each well and the plates incubated for another 2 h. Then the plates were read with a Spectramax Gemini XS microplate fluorometer using an excitation wavelength of 536 nm and an emission wavelength of 588 nm. Data were analysed using the microplate reader software Softmax Pro. Podophyllotoxin was the reference drug used [11] .
Colorimetric PfTrxR assay: For determining PfTrxR activity two different assay systems were employed. (i) In the DTNB reduction assay the enzyme was added to a mixture consisting of 100 mM potassium phosphate, 2 mM EDTA, pH 7.4, and 3 mM DTNB; after initiating the reaction with the addition of NADPH (200 µM final concentration), the increase in absorbance at 412 nm was monitored. One enzyme unit is defined as the NADPH-dependent production of 2 µM of 2-nitro-5-thiobenzoate per min. For obtaining the Vmax value, the Michaelis-Menten equation with a Km of 465 mM for DTNB was applied. (ii) In the Trx assay, the mixture contained the same buffer but varying TrxS 2 concentrations and 100 µM NADPH. The reaction was started with TrxR, and the decrease in absorbance at 340 nm was monitored [8] .
PfGR assay: This enzyme was assayed under the same conditions as PfTrxR but using GSSG as a disulfide substrate as per Kanzok et al. [8] .
